← Leaderboards
Anthony Venida
University Of California, San Francisco
$36,972
Attributed
$36,972
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$36,972 · 1
By mechanism
F31$36,972 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Jayanta Debnath$11,943,792
- Rushika Miriam Perera$8,181,227
- Adrian Erlebacher$16,886,170
- Matthew F Krummel$32,506,768
- Ophir D Klein$31,591,158
Others in their field
Other Emerging Leaders on “Anti-Ctla4”
- Sana D Karam · University Of Colorado Denver$3,185,899
- Evan Newell · Fred Hutchinson Cancer Research Center$2,763,230
- Patrick Alexander Ott · Dana-Farber Cancer Inst$2,499,237
- Gary Fanger · Rise Therapeutics, Llc$2,436,171
- Diwakar Davar · University Of Pittsburgh At Pittsburgh$2,361,425
- Zachary Conrad Hartman · Duke University$2,321,754
Research focus
Anti-Ctla4Antigen PresentationAnti-Pd-1Anti-Tumor Immune ResponseAntitumor ResponseAutophagocytosisAutophagosomeBaseBindingBiologyCancer CellCancer TherapyCd8-Positive T-LymphocytesCell MembraneCellsCell SurfaceChloroquineChronicCombined Modality TherapyComplexCtla4 GeneCytotoxicDestinationsAcute